May 15, 2023
1:10
For every 10 shares held, investors received 1. The price per share adjusted from $0.33 to $3.30.
The split itself did not change the total investment value.
Xenetic Biosciences, Inc. (NASDAQ:XBIO) operates in the Pharmaceuticals: major industry.
Xenetic Biosciences, Inc. company overviewXenetic Biosciences, Inc.'s most recent stock split was on May 15, 2023. It was a 1-for-10 reverse split, so shareholders received 1 share for every 10 they held.
Xenetic Biosciences, Inc. (NASDAQ:XBIO) has split its stock 5 times: a 10-for-1 split on March 1, 2013, a 1-for-10 reverse split on January 14, 2014, a 1-for-33 reverse split on June 6, 2016, a 1-for-12 reverse split on June 25, 2019, and a 1-for-10 reverse split on May 15, 2023.
Xenetic Biosciences, Inc. has split its stock 5 times. This history records 5 splits between March 1, 2013 and May 15, 2023.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Xenetic Biosciences, Inc.'s 1-for-10 reverse split on May 15, 2023, every 10 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
Xenetic Biosciences, Inc. has not announced a new split in our records. Its most recent split was on May 15, 2023, 3 years ago. Companies announce splits in advance, and any new NASDAQ:XBIO split will appear on this page.